Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2005 1
2006 3
2007 2
2008 3
2009 3
2010 4
2011 2
2012 3
2013 5
2014 4
2015 6
2016 4
2017 5
2018 8
2019 10
2020 8
2021 15
2022 17
2023 10
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
Wagenlehner FM, Gasink LB, McGovern PC, Moeck G, McLeroth P, Dorr M, Dane A, Henkel T; CERTAIN-1 Study Team. Wagenlehner FM, et al. N Engl J Med. 2024 Feb 15;390(7):611-622. doi: 10.1056/NEJMoa2304748. N Engl J Med. 2024. PMID: 38354140 Clinical Trial.
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway.
Huang B, Ren J, Ma Q, Yang F, Pan X, Zhang Y, Liu Y, Wang C, Zhang D, Wei L, Ran L, Zhao H, Liang C, Wang X, Wang S, Li H, Ning H, Ran A, Li W, Wang Y, Xiao B. Huang B, et al. Among authors: zhao h. Mol Cancer. 2024 Feb 15;23(1):34. doi: 10.1186/s12943-024-01940-0. Mol Cancer. 2024. PMID: 38360682 Free PMC article.
Plasmapheresis Therapy in Kidney Transplant Rejection.
Xie P, Tao M, Peng K, Zhao H, Zhang K, Sheng Y, Ankawi G, Ronco C. Xie P, et al. Among authors: zhao h. Blood Purif. 2019;47(1-3):73-84. doi: 10.1159/000493521. Epub 2018 Sep 25. Blood Purif. 2019. PMID: 30253400 Free article.
Efficacy and Safety of Sevelamer Carbonate in Chinese Nondialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized, Double-Blind, Parallel-Group Study.
Chen W, Liu HF, Chen QK, Zhao MH, Chen XN, Liu H, Wan JX, Li SM, Chen MH, Dai C, Shi HB, Wei JL, Zhao HW, Wang LH, Long G, Lu WH, Tang Y, Yang JW, Cao LY, Tang DX, Yang YQ, Yu XQ. Chen W, et al. Kidney Dis (Basel). 2022 Dec 15;9(2):82-93. doi: 10.1159/000527833. eCollection 2023 Apr. Kidney Dis (Basel). 2022. PMID: 37065610 Free PMC article.
A Study on Immune Cell Infiltration in Lung Adenocarcinoma.
Sun B, Zhao H. Sun B, et al. Among authors: zhao h. Comb Chem High Throughput Screen. 2022;25(12):2082-2088. doi: 10.2174/1386207325666220221100429. Comb Chem High Throughput Screen. 2022. PMID: 35189796
109 results